Original Research

Published on 13 Oct 2023

Immunotherapy with STING and TLR9 agonists promotes synergistic therapeutic efficacy with suppressed cancer-associated fibroblasts in colon carcinoma

in Cytokines and Soluble Mediators in Immunity

Sare Hajiabadi
Soodeh Alidadi
Zohreh Montakhab Farahi
Mohammad M. Ghahramani Seno
Hamidreza Farzin
Alireza Haghparast

Frontiers in Immunology

doi 10.3389/fimmu.2023.1258691

3,919 views
3 citations

Editorial

Published on 10 Oct 2023

Editorial: How to circumvent the tumour-promoting effect of cytokine in tumour therapy

in Cytokines and Soluble Mediators in Immunity

Lingman Ma
Jiakai Hou
Jian Dong
Yanbo Wang
Jifu Wei

Frontiers in Immunology

doi 10.3389/fimmu.2023.1298157

1,240 views

Review

Published on 04 Oct 2023

T cell Ca2+ microdomains through the lens of computational modeling

in Cytokines and Soluble Mediators in Immunity

Diana C. Gil Montoya
Roberto Ornelas-Guevara
Björn-Philipp Diercks
Andreas H. Guse
Geneviève Dupont

Frontiers in Immunology

doi 10.3389/fimmu.2023.1235737

2,162 views
4 citations

Review

Published on 29 Sep 2023

The clinical relevance of OSM in inflammatory diseases: a comprehensive review

in Cytokines and Soluble Mediators in Immunity

Cody L. Wolf
Clyde Pruett
Darren Lighter
Cheryl L. Jorcyk

Frontiers in Immunology

doi 10.3389/fimmu.2023.1239732

10,235 views
8 citations

Original Research

Published on 28 Sep 2023

Cytokine dysregulation despite immunoglobulin replacement therapy in common variable immunodeficiency (CVID)

in Cytokines and Soluble Mediators in Immunity

Remo Poto
Antonio Pecoraro
Anne Lise Ferrara
Alessandra Punziano
Gianluca Lagnese
Carla Messuri
Stefania Loffredo
Giuseppe Spadaro
Gilda Varricchi

Frontiers in Immunology

doi 10.3389/fimmu.2023.1257398

2,346 views
2 citations

Original Research

Published on 28 Sep 2023

Potential plasma biomarkers at low altitude for prediction of acute mountain sickness

in Cytokines and Soluble Mediators in Immunity

Haoran Guo
Qi Wang
Tao Li
Jingwen Chen
Chao Zhang
Ying Xu
Qing Chang
Hangyi Li
Weiqiang Sun
Ruidi Han

Frontiers in Immunology

doi 10.3389/fimmu.2023.1237465

3,213 views
6 citations

Review

Published on 28 Sep 2023

Interleukin 6: at the interface of human health and disease

in Cytokines and Soluble Mediators in Immunity

Elena Grebenciucova
Stephen VanHaerents

Frontiers in Immunology

doi 10.3389/fimmu.2023.1255533

16,849 views
28 citations

Original Research

Published on 22 Sep 2023

Extracellular vesicles as biomarkers for AIDS-associated non-Hodgkin lymphoma risk

in Cytokines and Soluble Mediators in Immunity

Laura E. Martínez
Larry I. Magpantay
Yu Guo
Priya Hegde
Roger Detels
Shehnaz K. Hussain
Marta Epeldegui

Frontiers in Immunology

doi 10.3389/fimmu.2023.1259007

2,928 views
1 citation

Original Research

Published on 22 Sep 2023

Attenuated IL-2 muteins leverage the TCR signal to enhance regulatory T cell homeostasis and response in vivo

in Cytokines and Soluble Mediators in Immunity

Shining Ma
Michelle So
Aazam Ghelani
Rohith Srivas
Anupama Sahoo
Robyn Hall
Wenjun Liu
Hao Wu
Sherman Yu
Shiping Lu

Frontiers in Immunology

doi 10.3389/fimmu.2023.1257652

4,151 views
4 citations

Original Research

Published on 20 Sep 2023

Modulation of intestinal IL-37 expression and its impact on the epithelial innate immune response and barrier integrity

in Cytokines and Soluble Mediators in Immunity

Laura Kröhn
Aline Azabdaftari
Julian Heuberger
Christian Hudert
Matthias Zilbauer
Tilman Breiderhoff
Philip Bufler

Frontiers in Immunology

doi 10.3389/fimmu.2023.1261666

3,921 views
2 citations

Methods

Published on 20 Sep 2023

A liquid chromatography-tandem mass spectrometry based method for the quantification of adenosine nucleotides and NAD precursors and products in various biological samples

in Cytokines and Soluble Mediators in Immunity

Johanna Hiefner
Johann Rische
Madeleine J. Bunders
Anna Worthmann

Frontiers in Immunology

doi 10.3389/fimmu.2023.1250762

3,517 views
4 citations

Original Research

Published on 18 Sep 2023

Soluble biomarkers of HIV-1-related systemic immune activation are associated with high plasma levels of growth factors implicated in the pathogenesis of Kaposi sarcoma in adults

in Cytokines and Soluble Mediators in Immunity

Benderli Christine Nana
Livo Forgu Esemu
Michael Ebangha Besong
Derrick Hyacinthe Nyasse Atchombat
Kazuhiro Ogai
Thérèse M. Patricia Sobgui
Chris Marco Mbianda Nana
Reine Medouen Ndeumou Seumko’o
Honoré Awanakan
Gabriel Loni Ekali

Frontiers in Immunology

doi 10.3389/fimmu.2023.1216480

1,704 views

Original Research

Published on 11 Sep 2023

Proteomic aptamer analysis reveals serum biomarkers associated with disease mechanisms and phenotypes of systemic sclerosis

in Cytokines and Soluble Mediators in Immunity

Francesca Motta
Antonio Tonutti
Natasa Isailovic
Angela Ceribelli
Giovanni Costanzo
Stefano Rodolfi
Carlo Selmi
Maria De Santis

Frontiers in Immunology

doi 10.3389/fimmu.2023.1246777

2,329 views
1 citation

Review

Published on 01 Sep 2023

IL-32 as a potential biomarker and therapeutic target in skin inflammation

in Cytokines and Soluble Mediators in Immunity

Alexandra Wallimann
Mirjam Schenk

Frontiers in Immunology

doi 10.3389/fimmu.2023.1264236

4,563 views
4 citations

Original Research

Published on 01 Sep 2023

Interleukin-36γ is causative for liver damage upon infection with Rift Valley fever virus in type I interferon receptor-deficient mice

in Cytokines and Soluble Mediators in Immunity

Martina Anzaghe
Marc A. Niles
Eugenia Korotkova
Monica Dominguez
Stefanie Kronhart
Samira Ortega Iannazzo
Ingo Bechmann
Malte Bachmann
Heiko Mühl
Georg Kochs

Frontiers in Immunology

doi 10.3389/fimmu.2023.1194733

2,186 views

Editorial

Published on 31 Aug 2023

Editorial: Role of stem cell derivatives in inflammatory diseases

in Cytokines and Soluble Mediators in Immunity

Cuiping Zhang
Zhe Li
Jianghuai Wang
Yongming Yao
Haihong Li
Xiaobing Fu

Frontiers in Immunology

doi 10.3389/fimmu.2023.1275068

1,236 views

Navigation group

Articles

Immunotherapy with STING and TLR9 agonists promotes synergistic therapeutic efficacy with suppressed cancer-associated fibroblasts in colon carcinoma

Editorial: How to circumvent the tumour-promoting effect of cytokine in tumour therapy

T cell Ca2+ microdomains through the lens of computational modeling

The clinical relevance of OSM in inflammatory diseases: a comprehensive review

Cytokine dysregulation despite immunoglobulin replacement therapy in common variable immunodeficiency (CVID)

Potential plasma biomarkers at low altitude for prediction of acute mountain sickness

Interleukin 6: at the interface of human health and disease

Extracellular vesicles as biomarkers for AIDS-associated non-Hodgkin lymphoma risk

Attenuated IL-2 muteins leverage the TCR signal to enhance regulatory T cell homeostasis and response in vivo

Modulation of intestinal IL-37 expression and its impact on the epithelial innate immune response and barrier integrity

A liquid chromatography-tandem mass spectrometry based method for the quantification of adenosine nucleotides and NAD precursors and products in various biological samples

Soluble biomarkers of HIV-1-related systemic immune activation are associated with high plasma levels of growth factors implicated in the pathogenesis of Kaposi sarcoma in adults

Proteomic aptamer analysis reveals serum biomarkers associated with disease mechanisms and phenotypes of systemic sclerosis

IL-32 as a potential biomarker and therapeutic target in skin inflammation

Interleukin-36γ is causative for liver damage upon infection with Rift Valley fever virus in type I interferon receptor-deficient mice

Editorial: Role of stem cell derivatives in inflammatory diseases